# reload+after+2024-01-20 11:36:12.517451
address1§4 Kingdom Street
address2§Floor 4 Unit 4B Paddington Central
city§London
zip§W2 6BD
country§United Kingdom
phone§44 20 4551 8888
website§https://www.etherapeutics.co.uk
industry§Biotechnology
sector§Healthcare
longBusinessSummary§e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet. The company was incorporated in 2001 and is based in London, the United Kingdom.
fullTimeEmployees§34
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Ahmad Ali Mortazavi', 'age': 52, 'title': 'CEO & Director', 'yearBorn': 1971, 'fiscalYear': 2023, 'totalPay': 270000, 'exercisedValue': 0, 'unexercisedValue': 1547654}, {'maxAge': 1, 'name': 'Mr. Timothy  Bretherton', 'title': 'CFO, Director of Finance & Operations and Company Secretary', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Laura  Roca-Alonso Ph.D.', 'title': 'Chief Operating Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Alan  Whitmore B.Sc., Ph.D.', 'title': 'Chief Scientific Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Alison  Gallafent', 'title': 'Chief Intellectual Property Officer', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ankit  Sharma', 'title': 'Head of Software Engineering', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Graham  Craggs', 'title': 'Head of Therapeutic Discovery', 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.392
priceToSalesTrailing12Months§193.18367
currency§GBp
exchange§LSE
quoteType§EQUITY
shortName§E-THERAPEUTICS PLC ORD 0.1P
longName§e-therapeutics plc
firstTradeDateEpochUtc§1196236800
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§f35f7cb5-8dfa-36fd-91da-c2351d657f4e
recommendationKey§none
quickRatio§19.708
grossMargins§1.0
ebitdaMargins§0.0
trailingPegRatio§None
